Skip to content
Monday 17 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,750.11
-0.21%
DAX
26,440.31
+0.53%
CAC 40
8,636.80
-0.16%
STOXX 50
6,539.59
-0.09%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Tuesday 09 December 2025 3:45 pm

No-zempic: Jolly Brits swap weight-loss jabs for stuffing this Christmas

By: Amber Murray

Retail Reporter

Add as a preferred source on Google
Four in 100 households in the UK now have at least one member using GLP-1, the active ingredient in weight-loss drugs like Ozempic.
Brits want to go all out this Christmas

Brits are set to go all out this Christmas as nearly half plan to swap out their weight loss jabs for an extra helping of turkey and pudding.

One in three don’t plan to return to their normal dose until after New Year in order to take full advantage of the festive season, according to data from Chequp.

The most commonly cited reason for pausing or cutting doses was wanting to “go all out and enjoy themselves” followed by feeling they “deserve a break”.

It’s great news for supermarkets, who have been worried that a rise in GLP medications this year will cut into sales of sweet treats and festive foods.

The share of UK households with at least one GLP-1 user has almost doubled in size from 2.3 per cent to 4.1 per cent in the last year, according to retail experts at Kantar, which has drawn a link between a decline in grocery sales volumes and an uptick in the popularity of weight-loss jabs.

In its latest annual food and drink report, Waitrose, too, found an increasing number of people replacing full meals with snacking foods.

Brits warned not to go cold Turkey

Despite one in ten Brits planning to cut out jabs completely over the festive period – compared to one in three who plan to reduce their dose – users have been warned not to dramatically cut out medication.

Read more

Fine dining and The Jab: A Michelin dinner with the Ozempic set

Ozempic tablet on a plate highlighting medications role in weight loss and diabetes management in healthcare news.

“Sopping GLP-1 treatment abruptly… can lead to rebound high blood sugar and rapid weight regain,” Aaron Arman, superintendent pharmacist at CheqUp. said.

“These risks are only heightened during a festive period typically associated with higher carbohydrate and sugar intake,” he added.

Patients who pause their medication may also experience stronger side effects when restarting, as the body loses its built-up tolerance.

Many GLP-1 users are – more safely – adapting their festive eating rather than giving up.

Six in ten said they would choose smaller portion sizes, while half planned to drink less alcohol and opt for lighter or lower‑calorie dishes, according to Chequp.



Read more

Oura Ring 5 vs Google Fitbit Air: The battle of the fitness trackers 

Close-up of Oura Ring 5 showcasing sleek design and advanced health tracking features in a tech-focused setting.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business
  • Healthcare

People & Organisations

  • Kantar
  • Ozempic
  • pharmacy
  • Waitrose
  • weight loss drugs

Trending Articles

  • Jobs market ‘stops moving’ as employment costs weigh on hirers

  • House prices suffer biggest August slump in eight years 

  • Back bookshops in bid to rebuild high streets, Burnham urged

  • Aldi boss wades into supermarket ‘price-gouging’ row

  • Reform pledges £50bn savings in ‘generational’ benefits shake-up

More from Morning Wire

  • Fine dining and The Jab: A Michelin dinner with the Ozempic set

    Life&Style
    Ozempic tablet on a plate highlighting medications role in weight loss and diabetes management in healthcare news.
  • Oura Ring 5 vs Google Fitbit Air: The battle of the fitness trackers 

    Life&Style
    Close-up of Oura Ring 5 showcasing sleek design and advanced health tracking features in a tech-focused setting.
  • The Burnham bounce won’t last unless Brits get better off

    Opinion
    Andy Burnham smiling and holding a pint of beer and a smartphone in a pub setting
  • Terry Smith dubs weight-loss giant Novo Nordisk ‘investment disaster’

    Investing
    Terry Smith, founder of Fundsmith, speaking at a business conference, wearing a suit and tie, with a focused expression.
  • Wealthy Brits fear Burnham tax consequences

    Personal Finance
    Andy Burnham, Mayor of Greater Manchester, speaking at a podium with microphones.
  • Burnham says Infantino ‘wrong man’ to lead Fifa as Brits back World Cup boycott plans

    Sport Business
    Andy Burnham speaking at a podium with microphones, gesturing with his hands, crowd in background
  • Brits think supermarkets are profiteering – despite slowing food inflation

    Retail
    Shopper with red backpack and blue basket walking through a supermarket aisle filled with groceries
  • IHT receipts hit record high as Rachel Reeves’ frozen bands raid plague Brits

    Personal Finance
    Inheritance tax receipts are on track for a record breaking year
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook